文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

PYGM双等位基因致病变异损害视网膜糖原分解并导致多种表型

Biallelic Pathogenic Variants in PYGM Impair Retinal Glycogenolysis Causing a Range of Phenotypes.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

本研究通过一个常染色体隐性遗传性黄斑营养不良家系的基因组测序发现PYGM纯合终止变异,并分析65例糖原贮积病V型(GSDV)患者的视网膜受累情况,发现30例存在视网膜病变,且年龄>60岁和男性患病率更高。小鼠和细胞实验显示PYGM在Müller胶质细胞和光感受器表达,PygmR50*/R50*小鼠光感受器外段变薄。结论提示GSDV与视网膜病变中度相关,建议视网膜监测并将PYGM纳入视网膜营养不良基因panel。

要点

  • GSDV患者中30/65例存在视网膜受累,23例为双侧,>60岁和男性更常见。
  • PYGM致病变异可表现为非综合征性遗传性黄斑营养不良,需视网膜监测。
  • 建议将PYGM纳入视网膜营养不良基因panel,PygmR50*/R50*小鼠显示光感受器外段变薄。

核心结论

  • GSDV与视网膜病变中度相关,可表现为非综合征性遗传性黄斑营养不良,需对患者进行视网膜监测并将PYGM纳入视网膜营养不良基因panel。

研究设计与样本

  • 对一个常染色体隐性遗传性黄斑营养不良家系进行表型分析和基因组测序,并分析65例GSDV患者(平均年龄51.7岁)的视网膜受累情况。
  • 采用免疫组化、RT-qPCR和翻译核糖体亲和纯化检测视网膜糖原磷酸化酶同工酶表达,在RPE-1细胞研究糖原分解,并检查PygmR50*/R50*小鼠视网膜切片。

主要发现

  • 基因组测序发现先证者及患病同胞携带PYGM纯合致病性终止变异(NM_005609.4:c.148C>T;p.[Arg50*]),重新表型分析显示GSDV特征。
  • 65例GSDV患者中30例存在视网膜受累(23例双侧),>60岁参与者患病率约高2.6倍,男性约高2倍。
  • PYGM表达定位于Müller胶质细胞和光感受器,小鼠视网膜和RPE-1细胞存在细胞类型特异性GP同工酶表达,RPE-1细胞显示糖原分解。
  • PygmR50*/R50*小鼠无糖原累积,但表现出光感受器外段变薄,与Pygm是小鼠光感受器主要表达同工酶一致。

临床怎么用

  • 对GSDV患者进行视网膜监测,尤其关注>60岁和男性患者。
  • 对非综合征性遗传性黄斑营养不良患者考虑PYGM基因检测,并将PYGM纳入视网膜营养不良基因panel。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Biallelic pathogenic variants in PYGM (glycogen myophosphorylase) cause glycogen storage disease V (GSDV), a skeletal muscle disorder with reported association with hereditary macular dystrophy (HMD). This study investigated the role of PYGM in HMD and broader retinal disease through clinical and functional analyses. METHODS: An autosomal recessive HMD family underwent phenotyping and genome sequencing. Separately, data from 65 patients with GSDV (mean age = 51.7 years) were analyzed for retinal involvement. Immunohistochemistry, RT-qPCR and translating ribosome affinity purification assays assessed retinal expression of glycogen phosphorylase (GP) isoenzymes. Glycogenolysis was studied in retinal pigment epithelial (RPE-1) cells. Retinal sections from PygmR50*/R50* mice were also examined. RESULTS: Genome sequencing identified a homozygous pathogenic stop-gain variant in PYGM (NM_005609.4:c.148C > T; p.[Arg50*]) in the proband and affected sibling, and re-phenotyping revealed features of GSDV. Retinal involvement was identified in 30 of 65 GSDV cases (23 bilateral), with higher prevalence in participants >60 years (approximately 2.6-fold) and men (approximately 2-fold). PYGM expression was localized to Müller glia and photoreceptors. Cell-type-specific GP isoenzyme expression was found in mouse retina and RPE-1 cells. RPE-1 cells demonstrated glycogenolysis. PygmR50*/R50* mice lacked glycogen accumulation but exhibited photoreceptor outer segment thinning consistent with Pygm being the predominant isoform expressed in mouse photoreceptors. CONCLUSIONS: GSDV is moderately associated with retinopathy, and may present as non-syndromic HMD, warranting retinal monitoring for patients, and the inclusion of PYGM in retinal dystrophy gene panels. Redundancy in retinal glycogenolysis may account for lower penetrance and higher age-related prevalence in patients. Photoreceptor thinning observed in PygmR50*/R50* mice strengthens the association between HMD and GSDV in humans.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Hussein R, Tayyib A, Lin S, et al. Biallelic Pathogenic Variants in PYGM Impair Retinal Glycogenolysis Causing a Range of Phenotypes. Invest Ophthalmol Vis Sci. 2026. PMID: 42725911. doi:10.1167/iovs.67.11.18

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。